Inhibition of CXCR4 reduces tumor invasion in glioblastoma cells and increases their sensitivity to radiotherapeutic agents while suppression of β1-integrin could favor cells not to settle around pre-existing blood vessels [67]. Here, CXCR4 is linked to neoplasm.